Doctor Visit Notes — Kamla Sharma

Date: 18 April 2026
Patient name in notes: Komal Devi (same person — Kamla Sharma)
Age: 63F

Chief Complaints

• 1st CMC joint pain bilateral hands — Right 10%, Left 20%
• Multiple toe pain (10%), Right foot
• Left thigh pain — 80% of total complaint (likely sciatica from L-S spine)

X-rays Ordered

• Bilateral hands AP
• L-S Spine AP + Lateral + Oblique (pendulum view)
• Bilateral foot

Prescription (10-day course) — VERIFIED COMPOSITIONS

What this prescription suggests (interpretive, not confirmed diagnoses)

1. The doctor is treating nerve-mediated pain empirically with Pregabalin + Nortriptyline (first-line agents for neuropathic pain, including sciatica). The prescription supports this interpretation, but does not confirm a definitive neuropathic-pain diagnosis without imaging or nerve studies.
2. No opioid — my earlier guess of “Tramadol” was WRONG. The pain control is NSAID + paracetamol + muscle relaxant + nerve pain agents. This is a thoughtful, non-opioid approach.
3. B12 1500 mcg/day is already covered by YOPREG-NM. She does not need additional B12 supplementation while on this medication.
4. High-dose Vitamin D loading — Arachitol injection (300,000 IU) + 2 × D3 ADEN 60,000 IU/week × 2 weeks = ~420,000 IU additional oral over 2 weeks. Total loading: ~540,000 IU over 2 weeks. Note: her last recorded Vitamin D was 40.2 ng/mL (sufficient range); the doctor’s loading dose may be empiric-therapeutic for musculoskeletal symptoms, OR the doctor may have access to more recent data showing it has dropped — this should be clarified.

Key Drug Interactions and Cautions

⚠️ HIGH-PRIORITY SAFETY FLAGS (Discuss with prescriber)

1. QT Prolongation Risk: Nortriptyline + Domperidone - Both Nortriptyline (in YOPREG-NM) and Domperidone (in ROWET-DSR) independently prolong the QT interval. - Combined risk in a 63-year-old female warrants a baseline ECG and discussion with the prescriber. - Risk factors: female sex, age >60, electrolyte imbalances (low K+, low Mg++), other QT-prolonging drugs. - This was NOT flagged in the original prescription review and should be raised at the next doctor visit.

2. Fall Risk Stack: Pregabalin + Nortriptyline + Chlorzoxazone - Three CNS-active drugs simultaneously, plus active sciatica. - Cumulative sedation, dizziness, and orthostatic risk are significant. - Practical measures: avoid sudden position changes, ensure good home lighting, no loose rugs, hold handrails, no nighttime ambulation without lights. - Exercise plan must be physiotherapist-supervised for the first 4-6 weeks given this stack.

3. NSAID Risks in 63F (Aceclofenac in KEDAC-CP+) - Even with Rabeprazole gastroprotection: GI bleeding risk persists, especially with prolonged use. - Renal: NSAIDs reduce renal blood flow; her eGFR was 89 (good but not optimal). Monitor BUN/creatinine after the course. - Cardiovascular: NSAIDs raise BP and CV event risk in elderly; she has elevated Lp(a) and low HDL — additive concern. - This is appropriate for short-course (10 days) but should NOT become a chronic regimen without doctor reassessment.

4. Anticholinergic Burden: Nortriptyline - Tricyclic antidepressants in elderly cause: dry mouth, constipation, urinary retention, blurred vision, confusion, sedation, orthostatic hypotension. - These overlap with what could be misinterpreted as new “symptoms” — important to attribute correctly. - If new constipation, confusion, or urinary issues develop → flag to prescriber, do not chase with extra supplements.

Other Cautions

• Pregabalin + Magnesium — additive CNS depression. Start magnesium low (200 mg) if added.
• Nortriptyline + serotonergic supplements — Avoid St. John’s Wort, 5-HTP.
• Aceclofenac + antiplatelet supplements — high-dose omega-3, curcumin, garlic, ginkgo could marginally increase bleeding risk during the NSAID course.
• Chlorzoxazone + Curcumin — both have rare hepatotoxicity. Keep curcumin at standard doses; monitor LFTs.
• High-dose Vitamin D loading — risk of hypercalcemia, especially if combined with other Vit D-active compounds (see K2-GOOD discussion below).

Still Unidentified

• T. Castrou — composition not yet verified. Ask pharmacist. Given 5-day course and clinical context (multiple GI-active drugs already), could be related to GI motility, constipation, or unrelated.

Doctor’s Implied Working Diagnoses (interpretive)

1. Osteoarthritis — bilateral 1st CMC joints and multiple toes (classic age/degeneration pattern; consistent with prescription, not confirmed without imaging)
2. Lumbar Spondylosis / Sciatica — L-S spine issue causing left thigh radiation (the dominant complaint; X-rays were ordered to investigate)
3. Vitamin D management — Loading dose prescribed. Her last recorded Vit D (Nov 2025) was 40.2 ng/mL (sufficient). The prescription suggests either: (a) doctor has more recent data showing decline, or (b) empiric therapeutic dose for musculoskeletal symptoms. Clarify with the doctor, as labelling this “Vitamin D deficiency” without a current low value would be unsupported.

Working Hypothesis: Metabolic Contributors to Musculoskeletal Pain

This is a working theory, NOT an established diagnosis. Her pain may be primarily structural (OA + lumbar spondylosis — both age-typical), with metabolic factors acting as secondary amplifiers. Magnitude of each contribution is unknown without further testing.

On the Hashimoto’s Hypothesis

Subclinical hypothyroid + elevated IgE + elevated CRP is NOT a textbook Hashimoto’s pattern. Hashimoto’s diagnosis requires positive Anti-TPO and/or Anti-Thyroglobulin antibodies. This is a hypothesis to TEST via antibody panel — not a confirmed pattern. Many other conditions could produce this same lab picture.

Practical takeaway: Addressing confirmed deficiencies (B12, calcium, Vit D maintenance) is reasonable regardless of the structural picture. But do not assume the metabolic correction will resolve all pain — structural treatment (X-ray-guided) may still be needed.